Related Experiment Video

Updated: Jun 13, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Management of the patient with statin intolerance

Byron F Vandenberg1, Jennifer Robinson

  • 1Division of Cardiovascular Medicine, Department of Internal Medicine, University of Iowa Hospitals and Clinics, 200 Hawkins Drive, Iowa City, IA 52242, USA. byron-vandenberg@uiowa.edu

Current Atherosclerosis Reports
|April 29, 2010
PubMed

Insights

Statin intolerance is common, but managing it involves dechallenge/rechallenge and alternative therapies. Strategies include switching statins, lifestyle changes, or other cholesterol-lowering medications for cardiovascular event prevention.

Area of Science:

  • Cardiology
  • Pharmacology
  • Preventive Medicine

Background:

  • Statins are recommended for lowering low-density lipoprotein cholesterol (LDL-C) and preventing cardiovascular events.
  • Patients frequently report adverse effects during statin therapy, leading to intolerance.

Purpose of the Study:

  • To review strategies for managing statin intolerance.
  • To discuss diagnostic approaches and therapeutic alternatives for patients unable to tolerate statins.

Main Methods:

  • Literature review of current guidelines and research on statin intolerance.
  • Discussion of diagnostic methods, including statin dechallenge and rechallenge.
  • Overview of management strategies and alternative LDL-C lowering agents.

Main Results:

  • Statin dechallenge and rechallenge are key to confirming intolerance.
  • Management options include switching statins, altered dosing, lifestyle changes, and alternative medications.
  • Emerging therapies for LDL-C reduction are under investigation.

Conclusions:

  • Effective management of statin intolerance is crucial for cardiovascular event prevention.
  • A stepwise approach involving diagnostic confirmation and tailored therapeutic strategies ensures optimal patient care.
  • Further research into novel LDL-C lowering therapies is warranted.

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...